REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN)
CUSIP: 75886F107
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 104,986,330
- Total 13F shares
- 91,953,885
- Share change
- -738,036
- Total reported value
- $66,140,528,710
- Put/Call ratio
- 115%
- Price per share
- $718.54
- Number of holders
- 1,156
- Value change
- -$553,052,249
- Number of buys
- 470
- Number of sells
- 573
Quarterly Holders Quick Answers
What is CUSIP 75886F107?
CUSIP 75886F107 identifies REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 75886F107:
Top shareholders of REGN - REGENERON PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
9%
|
9,440,096
|
$7,756,643,117 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
9%
|
9,418,300
|
$7,738,734,725 | — | 31 Mar 2023 | |
| VANGUARD GROUP INC |
13F
|
Company |
8.4%
|
8,852,121
|
$7,273,522,262 | — | 31 Mar 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
6%
|
6,344,151
|
$5,212,800,224 | — | 31 Mar 2023 | |
| Capital World Investors |
13F
|
Company |
5.6%
|
5,830,586
|
$4,790,765,482 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
4.7%
|
4,893,616
|
$4,020,930,869 | — | 31 Mar 2023 | |
| DODGE & COX |
13F
|
Company |
2.3%
|
2,384,701
|
$1,959,437,271 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.1%
|
2,217,993
|
$1,818,765,990 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.1%
|
2,178,232
|
$1,789,789,000 | — | 31 Mar 2023 | |
| Capital International Investors |
13F
|
Company |
2.1%
|
2,153,472
|
$1,769,443,338 | — | 31 Mar 2023 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1.7%
|
1,767,919
|
$1,452,646,006 | — | 31 Mar 2023 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.3%
|
1,312,407
|
$1,078,365,000 | — | 31 Mar 2023 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
1.1%
|
1,165,317
|
$957,506,028 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.1%
|
1,154,573
|
$948,677,998 | — | 31 Mar 2023 | |
| NORGES BANK |
13F
|
Company |
0.95%
|
1,001,113
|
$822,584,519 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.95%
|
993,968
|
$816,714,042 | — | 31 Mar 2023 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.92%
|
961,710
|
$783,251,566 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.9%
|
947,410
|
$778,458,373 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.87%
|
912,276
|
$749,591,453 | — | 31 Mar 2023 | |
| Invesco Ltd. |
13F
|
Company |
0.84%
|
884,755
|
$726,976,643 | — | 31 Mar 2023 | |
| Legal & General Group Plc |
13F
|
Company |
0.81%
|
849,127
|
$697,701,177 | — | 31 Mar 2023 | |
| Amundi |
13F
|
Individual |
0.74%
|
772,215
|
$637,244,519 | — | 31 Mar 2023 | |
| Neuberger Berman Group LLC |
13F
|
Company |
0.66%
|
688,879
|
$565,951,874 | — | 31 Mar 2023 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.63%
|
666,184
|
$547,383,409 | — | 31 Mar 2023 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.6%
|
633,508
|
$520,489,783 | — | 31 Mar 2023 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.58%
|
612,886
|
$503,590,040 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.57%
|
595,604
|
$489,390,175 | — | 31 Mar 2023 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.55%
|
573,812
|
$471,484,106 | — | 31 Mar 2023 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
0.53%
|
551,526
|
$453,172,368 | — | 31 Mar 2023 | |
| VAGELOS P ROY |
3/4/5
|
Director |
—
class O/S missing
|
467,104
|
$444,337,350 | — | 03 Apr 2023 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.47%
|
489,784
|
$402,440,832 | — | 31 Mar 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.42%
|
435,778
|
$358,066,103 | — | 31 Mar 2023 | |
| Sustainable Growth Advisers, LP |
13F
|
Company |
0.41%
|
432,997
|
$355,780,645 | — | 31 Mar 2023 | |
| PICTET ASSET MANAGEMENT SA |
13F
|
Company |
0.41%
|
428,903
|
$352,416,728 | — | 31 Mar 2023 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.41%
|
427,896
|
$351,589,000 | — | 31 Mar 2023 | |
| Swiss National Bank |
13F
|
Company |
0.4%
|
425,000
|
$349,209,750 | — | 31 Mar 2023 | |
| Capital Research Global Investors |
13F
|
Company |
0.4%
|
421,040
|
$345,955,937 | — | 31 Mar 2023 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.36%
|
373,138
|
$306,596,300 | — | 31 Mar 2023 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.34%
|
357,948
|
$294,127,554 | — | 31 Mar 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.33%
|
350,865
|
$288,295,245 | — | 31 Mar 2023 | |
| S.c.a. Candriam |
13F
|
Individual |
0.33%
|
348,988
|
$263,936,577 | — | 31 Mar 2023 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.29%
|
302,752
|
$248,762,236 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.28%
|
291,246
|
$239,308,101 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.26%
|
276,573
|
$227,252,000 | — | 31 Mar 2023 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.24%
|
255,800
|
$210,075,667 | — | 31 Mar 2023 | |
| Chevy Chase Trust Holdings, LLC |
13F
|
Company |
0.24%
|
254,468
|
$209,088,722 | — | 31 Mar 2023 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.23%
|
240,774
|
$197,726,017 | — | 31 Mar 2023 | |
| Allianz Asset Management GmbH |
13F
|
Company |
0.22%
|
234,435
|
$192,628,206 | — | 31 Mar 2023 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.21%
|
223,675
|
$183,787,002 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.2%
|
209,800
|
$172,386,366 | — | 31 Mar 2023 |
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) as of Q2 2023
As of 30 Jun 2023,
REGENERON PHARMACEUTICALS, INC. - Common Stock (REGN) was held by
1,156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
91,953,885 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., VANGUARD GROUP INC, JPMORGAN CHASE & CO, Capital World Investors, STATE STREET CORP, Capital International Investors, Dodge & Cox, GEODE CAPITAL MANAGEMENT, LLC, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
1,158
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
1,182
Q2 2023 holders
1,156
Holder diff
-26
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.